Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Catheter Evaluation for Endocardial Ablation in Patients With Ventricular Tachycardia

Study:

NaviStar ThermoCool Catheter for Endocardial RF Ablation in Patients With Ventricular Tachycardia

Rationale:

n/a

Purpose:

The primary objective is to provide additional corroborative safety and efficacy data for the Navistar ThermoCool catheter for the treatment of subjects with ischemic Ventricular Tachycardia.

Study Status: Active, not recruiting

Recruiting:
n/a

Condition Intervention Phase
Ventricular Tachycardia Device: NAVISTAR® THERMOCOOL® Catheter Phase 4

Verified by Biosense Webster, Inc. September, 2011

Sponsored by: Biosense Webster, Inc.
Information provided by: Biosense Webster, Inc.
ClinicalTrials.gov identifier: NCT00412607

Study Type: Interventional

Study Design: Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

Cleveland Clinic Foundation
Cleveland, Ohio 44195
United States

n/a

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.